Company: LICN
Filing Date: 2025-01-31
Form Type: 6-K
Source: 0001213900-25-008867
Chunk: 1

Company: Lichen International Ltd
Filing Date: 2025-01-31
Form: 6-K
Chunk 1
---
 beneficially owning more than 9.99% of the outstanding share capital of the
Company following the consummation of January 28 Registered Direct Offering. Each Pre-Funded Warrant represents the right to purchase
one Class A Ordinary Share at an exercise price of $0.001 per share. The Pre-Funded Warrants are exercisable immediately and may be exercised
at any time until the Pre-Funded Warrants are exercised in full (subject to the beneficial ownership limitation described above). As of
the date of this report, 3,900,000 Pre-Funded Warrants have been exercised and the Company has issued 3,900,000 Class A Ordinary Shares
as a result of such exercise.

The Purchase Agreement contains
customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the
Company, other obligations of the parties, and termination provisions.

<div align='center'>1</div>

In addition, the Company agreed
that for a period of sixty (60) days from the closing date of January 28 Registered Direct Offering, it will not: (i) issue, enter into
any agreement to issue or announce the issuance or proposed issuance of any Class A Ordinary Shares or equivalent securities; or (ii)
file any registration statement or amendment or supplement thereto (other than on Form S-8 or in connection with the registration for
resale of the Class A Ordinary Shares). In addition, the Company agreed that it will not conduct any sales of Class A Ordinary Shares
or equivalent securities involving a variable rate transaction (as defined in the Purchase Agreement) for a period of ninety (90) days
from the closing date of January 28 Registered Direct Offering, subject to certain exceptions as described in the Purchase Agreement.

The Shares, the Pre-Funded
Warrants and the Class A Ordinary Shares underlying the Pre-funded Warrants (together with the Shares and the Pre-Funded Warrants, the
“Securities”) were offered by the Company pursuant to a registration statement on Form F-3 (File No. 333-277230) (the “Registration
Statement”), previously filed and declared effective by the Securities and Exchange Commission (the “Commission”) on
March 1, 2024, the base prospectus filed as part of the Registration Statement, and the prospectus supplement dated January 28, 2025 (the
“Prospectus Supplement”).

On January 28, 2025, the Company
entered into